Dr. Carpentier shares his experience with and looks into the science behind the use of dexamphetamine treatment as a novel off-label treatment for a number of female chronic disorders that do not respond well to conventional therapy including recurrent pregnancy loss, inflammation, and ongoing pain. The primary article of focus for this journal club, “The neurotransmitter dopamine modulates vascular permeability in the endothelium”, along with a list of references can be downloaded to accompany the webinar.
Women with elevated natural killer (NK) cell frequency and function during pregnancy, suffer from recurrent pregnancy loss (RPL). In the present study, the possible effect of intravenous immunoglobulin (IVIG) administration on Th1 and Th2 cell frequency, cytokine secretion, and expression of transcription factors is compared between RPL patients and control group. This article is explored in this months Journal Club.
Presented by Dr. Joseph Stanford Referenced Article: Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss. Stephenson, […]
Presented by Drs. Joseph Stanford and Paul Carpentier We’re sorry, this content is only available to current IIRRM Members. Please Log […]
Early Supplementation of Progestogens to Prevent Miscarriage February 2017 Journal Club Presented by Dr. Joseph Stanford REF: Saccone, Gabriele & […]
A Randomized Trial of Progesterone in Women with Recurrent Miscarriages January Journal Club with Dr. Paul Carpentier REF Article: Coomarasamy, […]
Research Updates from Dr. Luke McLindon, Australia.
Grand Rounds: The Fertility Assessment Research Clinic Mater Mother’s Hospital Dec. 2012 We’re sorry, this content is only available to […]